Laffel LM - Search Results

1

Continuous Ketone Monitoring Consensus Report 2021.

Nguyen KT, Xu NY, Zhang JY, Shang T, Basu A, Bergenstal RM, Castorino K, Chen KY, Kerr D, Koliwad SK, Laffel LM, Mathioudakis N, Midyett LK, Miller JD, Nichols JH, Pasquel FJ, Prahalad P, Prausnitz MR, Seley JJ, Sherr JL, Spanakis EK, Umpierrez GE, Wallia A, Klonoff DC. Nguyen KT, et al. Among authors: laffel lm. J Diabetes Sci Technol. 2022 May;16(3):689-715. doi: 10.1177/19322968211042656. Epub 2021 Oct 4. J Diabetes Sci Technol. 2022. PMID: 34605694 Free PMC article.

2

Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes.

Laffel L. Laffel L. Diabetes Metab Res Rev. 1999 Nov-Dec;15(6):412-26. doi: 10.1002/(sici)1520-7560(199911/12)15:6<412::aid-dmrr72>3.0.co;2-8. Diabetes Metab Res Rev. 1999. PMID: 10634967 Review.

3

Use of an automated device for alternative site blood glucose monitoring.

Fineberg SE, Bergenstal RM, Bernstein RM, Laffel LM, Schwartz SL. Fineberg SE, et al. Among authors: laffel lm. Diabetes Care. 2001 Jul;24(7):1217-20. doi: 10.2337/diacare.24.7.1217. Diabetes Care. 2001. PMID: 11423505

4

Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial.

Laffel LM, Wentzell K, Loughlin C, Tovar A, Moltz K, Brink S. Laffel LM, et al. Diabet Med. 2006 Mar;23(3):278-84. doi: 10.1111/j.1464-5491.2005.01771.x. Diabet Med. 2006. PMID: 16492211 Clinical Trial.

5

Can we prevent diabetic ketoacidosis in children?

Bismuth E, Laffel L. Bismuth E, et al. Pediatr Diabetes. 2007 Oct;8 Suppl 6:24-33. doi: 10.1111/j.1399-5448.2007.00286.x. Pediatr Diabetes. 2007. PMID: 17727382 Review.

6

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group. Bergenstal RM, et al. N Engl J Med. 2010 Jul 22;363(4):311-20. doi: 10.1056/NEJMoa1002853. Epub 2010 Jun 29. N Engl J Med. 2010. PMID: 20587585 Free article. Clinical Trial.

7

Rubin RR, Peyrot M; STAR 3 Study Group. Rubin RR, et al. Diabetes Technol Ther. 2012 Feb;14(2):143-51. doi: 10.1089/dia.2011.0162. Epub 2011 Dec 1. Diabetes Technol Ther. 2012. PMID: 22133037 Free PMC article. Clinical Trial.

8

Psychosocial correlates of continuous glucose monitoring use in youth and adults with type 1 diabetes and parents of youth.

Markowitz JT, Pratt K, Aggarwal J, Volkening LK, Laffel LM. Markowitz JT, et al. Among authors: laffel lm. Diabetes Technol Ther. 2012 Jun;14(6):523-6. doi: 10.1089/dia.2011.0201. Epub 2012 Apr 23. Diabetes Technol Ther. 2012. PMID: 22524590 Free PMC article. Clinical Trial.

9

Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes.

Rasbach LE, Atkins AE, Milaszewski KM, Keady J, Schmidt LM, Volkening LK, Laffel LM. Rasbach LE, et al. Among authors: laffel lm. J Diabetes Sci Technol. 2014 May;8(3):494-7. doi: 10.1177/1932296814528135. Epub 2014 Mar 22. J Diabetes Sci Technol. 2014. PMID: 24876612 Free PMC article.

10

Type 1 diabetes through the life span: a position statement of the American Diabetes Association.

Chiang JL, Kirkman MS, Laffel LM, Peters AL; Type 1 Diabetes Sourcebook Authors. Chiang JL, et al. Among authors: laffel lm. Diabetes Care. 2014 Jul;37(7):2034-54. doi: 10.2337/dc14-1140. Diabetes Care. 2014. PMID: 24935775 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

412 results

Search Page